Offer - Urjas Oil for just ₹ 1 X
Metffil G1, a prescription drug, is manufactured in various forms such as Tablet. Primarily, it is used for the treatment of Diabetes. Metffil G1 also has some secondary and off-label uses. These are listed below.
The right dosage of Metffil G1 depends on the age, gender, and medical history of the patient. Dosage also depends on the route of administration and your chief complaint for which the drug is prescribed. Refer to the dosage section for a detailed discussion.
Metffil G1 also has some side effects, the most common being Headache, Nausea or vomiting, Dizziness. Besides the aforementioned side effects, there are other adverse effects of Metffil G1 as well, which are listed below. Such side effects of Metffil G1 normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Metffil G1's effect during pregnancy is Unknown and Safe while nursing. It is important to know if Metffil G1 has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Metffil G1 related warnings section.
Individuals suffering from medical conditions like Heart Disease, Kidney Disease, Liver Disease must refrain from the use of Metffil G1 since this can cause severe adverse effects. Some other conditions that can be affected by Metffil G1 are listed in the contraindications section below.
Besides this, Metffil G1 may also have severe interaction with some medicines. A complete list of these interactions is given below.
You should also be aware that Metffil G1 is not safe while driving, and is not addiction.
Metffil G1 is used to treat the following -
Main Benefits
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Metffil G1 safe for pregnant women?
The effects of Metffil G1 on pregnant women are unknown since no research has been done to ascertain it yet.
Is the use of Metffil G1 safe during breastfeeding?
Metffil G1 does not show any side effects in breastfeeding women.
What is the effect of Metffil G1 on the Kidneys?
Kidney can be affected by Metffil G1. If you experience any unwanted effects of this drug, stop taking it. You should take it again only after medical advice.
What is the effect of Metffil G1 on the Liver?
Metffil G1 may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Metffil G1 on the Heart?
Metffil G1 has very mild side effects on the heart.
Metffil G1 should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
Mild
If you are suffering from any of the following diseases, you should not take Metffil G1 unless your doctor advises you to do so -
Is this Metffil G1 habit forming or addictive?
Metffil G1 does not cause addiction.
Is it safe to drive or operate heavy machinery when consuming?
After taking Metffil G1 you may feel sleepy. So it is not advised to perform these activities.
Is it safe?
Yes, but consume Metffil G1 only on doctor's advice.
Is it able to treat mental disorders?
Metffil G1 is unable to treat or cure mental disorders.
Interaction between Food and Metffil G1
Information is not available on the interaction of any foods with Metffil G1, due to a lack of research on this.
Interaction between Alcohol and Metffil G1
No research has been done on this till date. Therefore, it is not known what the effect of taking Metffil G1 with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Amaryl (glimepiride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 272
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1156-1158
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826